封面
市場調查報告書
商品編碼
1271215

虛擬臨床試驗市場,實驗各類型,各階段,各企業規模,各治療領域,各地區-規模,佔有率,展望,機會分析,2023年~2030年

Virtual Clinical Trials Market, By Study Type, By Phases, By Company Size, By Therapeutic Area, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: | 出版商: Coherent Market Insights | 英文 161 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

虛擬臨床試驗是一種使用技術和線上社交參與平台進行臨床研究的相對較新的方法。虛擬試驗有可能推動臨床研究方法的重大數位化變革,從而創建一個改進的以患者為中心的生態系統。虛擬臨床試驗以數位方式授權臨床試驗過程。

疾病負擔增加、虛擬臨床試驗採用率的飆升、遠程醫療採用率的上升、新技術採用率的上升、醫療保健數位化的上升、技術進步以及 COVID-19(大流行)的爆發預計將是成長的主要因素,在預測期內推動全球虛擬臨床試驗市場的成長。

本報告對全球虛擬臨床試驗市場進行了深入分析,並提供了預測期(2023-2030年)的市場規模(百萬美元)和年複合成長率(CAGR%),以2022年為基準年。

目錄:

第1章 調查的目的與前提條件

  • 調查的目的
  • 前提條件
  • 簡稱

第2章 市場展望

  • 報告概要
    • 市場定義和規模
  • 摘要整理
    • 市場概述:各研究類型
    • 市場概述:各階段
    • 市場概述:各企業規模
    • 市場概述:各治療領域
    • 市場概述:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 全球虛擬臨床試驗數增加
    • 虛擬臨床試驗相關的課題
    • 疾病負擔增加和COVID-19發生
  • 影響度分析
  • 主要的焦點
  • 法律規章情境
  • 產品銷售/核准
  • PEST分析
  • PORTER的分析
  • 合併、收購情境

第4章 虛擬臨床試驗的全球市場-冠狀病毒(COVID-19)大流行造成的的影響

  • 關於COVID-19流行病學
  • 供給側和需求側的分析
  • 經濟影響

第5章 虛擬臨床試驗的全球市場,各實驗類型,2017年~2030年

  • 介入
  • 其他

第6章 虛擬臨床試驗的全球市場,各階段,2017年~2030年

  • 後期階段
  • 初期階段

第7章 虛擬臨床實驗的全球市場,各企業規模,2017年~2030年

  • 中堅、中小企業
  • 大企業

第8章 虛擬臨床試驗的全球市場:各治療領域,2017年~2030年

  • 腫瘤學
  • 罕見疾病、遺傳性疾病
  • 中樞神經系統
  • 免疫學
  • 其他

第9章 虛擬臨床試驗的全球市場,各地區,2017年~2030年

  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲地區

第10章 競爭情形

  • Delve Health
  • Clario
  • Clinical Ink
  • Castor
  • Accenture
  • Thread
  • Science 37
  • Medable
  • Dassault Systemes
  • eElinicalHealth(CLINPAL)

第11章 Section

  • 關於調查手法
  • 關於出版社
簡介目錄
Product Code: CMI5658

Virtual clinical trials is a relatively new method of conducting clinical research using technologies and online social engagement platforms. Virtual trials have the potential to drive significant digital alterations in the clinical research methodologies to create an improved patient-centric ecosystem. Virtual clinical trials are digitally empowered the clinical trial process.

Market Dynamics:

Growing burden of diseases, spike in virtual clinical trials adoption, rise in adoption of telehealth, rise in adoption of novel technologies, rise in healthcare digitization, technological advancements, and the outbreak of COVID-19 (pandemic) are major factors expected to boost the growth of the global virtual clinical trials market during the forecast period.

For instance, in November 2019, Johnson & Johnson in collaboration with PRA Health Sciences, launched the clinical trial set-up CHIEF-HF, a completely decentralize, indication-seeking, mobile clinical study. The company aims to utilize wearable devices and smart technology to efficiently gather and analyze evidence for assessing effectiveness of Canagliflozin in the populace with heart failure with presence of absence of type 2 diabetes.

Key features of the study:

  • This report provides in-depth analysis of the global virtual clinical trials market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global virtual clinical trials market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Delve Health, Clario, Clinical Ink, Castor, Accenture, Thread, Science 37, Medable, Dassault Systemes, and eElinicalHealth (CLINPAL), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global virtual clinical trials market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global virtual clinical trials market.

Detailed Segmentation:

  • Global Virtual Clinical Trials Market, By Study Type:
    • Interventional
    • Others
  • Global Virtual Clinical Trials Market, By Phases:
    • Late Stage
    • Early Stage
  • Global Virtual Clinical Trials Market, By Company Size:
    • Small- & Mid-sized
    • Large-sized
  • Global Virtual Clinical Trials Market, By Therapeutic Area:
    • Oncology
    • Rare & Genetic Diseases
    • CNS
    • Immunology
    • Others
  • Global Virtual Clinical Trials Market, By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Delve Health
    • Clario
    • Clinical Ink
    • Castor
    • Accenture
    • Thread
    • Science 37
    • Medable
    • Dassault Systemes
    • eElinicalHealth (CLINPAL)

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Study Type
    • Market Snapshot, By Phases
    • Market Snapshot, By Company Size
    • Market Snapshot, By Therapeutic Area
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increase in number of virtual clinical trials worldwide
    • Challenges associated with virtual clinical trials
    • Growing burden of diseases and outbreak of COVID-19
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Virtual Clinical Trials Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Virtual Clinical Trials Market, By Study Type, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Interventional
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Virtual Clinical Trials Market, By Phases, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Late Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Early Stage
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

7. Global Virtual Clinical Trials Market, By Company Size, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Small- & Mid-sized
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Large-sized
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

8. Global Virtual Clinical Trials Market, By Therapeutic Area, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Rare & Genetic Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • CNS
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Immunology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

9. Global Virtual Clinical Trials Market, By Geography, 2017-2030, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Study Type, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Phases, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Company Size, 2017-2030,(US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Area, 2017-2030,(US$ Mn)

10. Competitive Landscape

  • Delve Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clario
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Clinical Ink
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Castor
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Accenture
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thread
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Science 37
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Medable
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Dassault Systemes
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • eElinicalHealth (CLINPAL)
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us